KeyBank National Association
LAB icon

KeyBank National Association’s Standard BioTools LAB Stock Holding History

KeyBank National Association’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-16,927
Closed -$123K – 1153
2016
Q4 		$123K Hold
16,927
– – ﹤0.01% 1115
2016
Q3 		$136K Hold
16,927
– – ﹤0.01% 1117
2016
Q2 		$153K Hold
16,927
– – ﹤0.01% 1064
2016
Q1 		$137K Hold
16,927
– – ﹤0.01% 1061
2015
Q4 		$183K Hold
16,927
– – ﹤0.01% 1071
2015
Q3 		$137K Hold
16,927
– – ﹤0.01% 1096
2015
Q2 		$410K Buy
+16,927
New +$534K ﹤0.01% 896

Other funds holding LAB

LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

KeyBank National Association's LAB Position: Q1 2017 in Review

KeyBank National Association sold out of Standard BioTools (LAB) in Q1 2017, closing a stake of 16,927 shares — an estimated $123K sold.

KeyBank National Association first reported a position in LAB in Q2 2015 and held it in 7 quarters. The position peaked at $410K in Q2 2015. 80 funds tracked by Wall St. Rank hold LAB as of Q1 2017.

  • KeyBank National Association reported no remaining Standard BioTools position as of Q1 2017 after selling out during the quarter.
  • KeyBank National Association sold 16,927 Standard BioTools shares in Q1 2017, an estimated $123K.
  • KeyBank National Association first reported a position in Standard BioTools in Q2 2015 and held it in 7 quarters.
  • KeyBank National Association's Standard BioTools position peaked at $410K in Q2 2015.
  • 80 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2017.

Based on KeyBank National Association's 13F filing for Q1 2017, filed 9 May 2017.